• Robert Vince

    Prof. Robert Vince honored for his innovative work

    Prof. Robert Vince received the Impact Award at the inaugural presentation of the Innovation Awards (2014). At the ceremony, Made in Minnesota: Celebrating University Innovators, President Kaler awarded the trophy to Prof Vince.

    Watch the video about his innovation.

  • Dr. Vince and More

    Research on Alzheimer's Disease by Prof Vince and Prof More Featured on C&EN News

    Eye Test Might One Day Diagnose Alzheimer’s Before Symptoms Appear

    Prof Swati More and Prof Robert Vince have developed a noninvasive imaging technique that tracks accumulation of the Alzheimer’s peptide, amyloid-β, in the eye. The pair have peered into the retinas of mice with their patented, microscope-based method, they hope to one day use it to identify Alzheimer’s disease in human patients years before symptoms manifest.

    Read more

  • OakleyOriginals/CC 2.0/ flic.kr/p/5pjoeg
    OakleyOriginals/CC 2.0/ flic.kr/p/5pjoeg

    Prof Chen's Research on Parkinson’s Disease featured by the University

    Drug Design for Parkinson’s Disease Starts Here

    Recently, University of Minnesota Center for Drug Design member, organic chemist and assistant professor Prof Liqiang Chen, published a paper in the Journal of Medicinal Chemistry outlining the discovery of a potent and selective protein-inhibitor. Blocking the protein, Sirtuin 2 (SIRT2), also has the potential to block a primary contributor to Parkinson’s disease from causing harm.
    Read more

  • Salomon with bats

    Underground Research Drives Drug Research

    Prof Salomon's Research Highlighted in MNDaily

    University of Minnesota researchers have been studying microorganisms living in the Soudan Underground Mine, 224 miles north of the Twin Cities. For about five years, they’ve catalogued the organisms capable of living there despite the mine’s harsh conditions, and they hope that their discoveries will lead them to new treatments for disease and new technology.

    Read more

Message from the Director

Robert Vince

Robert Vince, PhD

The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices. The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value  for our academic and research community.

Read the full message

Next Seminar

Susan Mooberry, PhD

Susan Mooberry, PhD
Professor of Pharmacology and Co-leader of Experimental & Developmental Therapeutics
Cancer Therapy & Research Center
The University of Texas Health Science Center at San Antonio

Title: The Bat Flower: Source of Next Generation Microtubule Stabilizers
Date: May 20, 2015 
Time: 10:30 - 11:30 AM
Venue: 1-451 Moos Tower


Spotlight on Research

Alzheimer’s Disease Research

Profs Robert Vince and Swati More have developed a noninvasive imaging technique that tracks accumulation of the Alzheimer’s peptide, amyloid-β, in the eye.

Pre-Clinical Study for Cyanide Antidote

A faster acting and safer than existing options, an antidote for cyanide poisoning that works prophylactically to prevent or limit toxicity associated from exposure to cyanide has been developed.

CDD Functional Cosmetic

The Center for Drug Design has developed compounds that not only protect the skin from UV damage but also activate the enzymes which repair damaged DNA in the skin.